Dr. Raphael Lotan is a distinguished medical professional with a multifaceted background encompassing medicine, health technology, business administration, and mediation. He completed his Doctor of Medicine degree at the Hebrew University of Jerusalem in 1999 and furthered his skills with a Master of Health Administration in 2016.Dr. Lotan has significantly contributed to spinal health research. His impactful paper on "Diabetes mellitus as a risk factor for developing lumbar spinal stenosis" has received significant recognition. He has also made noteworthy contributions to the study of chronic non-specific low back pain and conjoined lumbosacral nerve roots.He extended his interests to HealthTech, studying Directors and Corporate Governance. Recently, he co-founded Augmedic Inc. and Epidutech Inc., where he served as the Chief Medical Officer, embodying his dedication to healthcare innovation. His work on novel techniques such as "XX'–Sacroplasty" and "Double-Balloon Kyphoplasty" and exploration into the role of cannabis in treating resistant fibromyalgia demonstrate his forward-thinking and inventive approach.Dr. Lotan's multi-disciplinary expertise and leadership in the startup ecosystem mark him as a formidable force in the healthcare sector, poised to make continued substantial contributions.